| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8712c4737b2f5c281cf3d9a5dec57962 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1682
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2014-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f9928016e57d008a650d7f4a2585a2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdb78f7bcfd6d411145365b42e3843ad |
| publicationDate |
2019-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-369035-B |
| titleOfInvention |
SOLID DOSAGE UNIT OF ORAL DISSOLUTION CONTAINING A COMPONENT OF ESTETROL. |
| abstract |
The present invention provides an oral solid pharmaceutical dosage unit having a weight of 50-1,000 mg and containing at least 0.1 mg of an estetrol component selected from estetrol, estetrol esters and combinations thereof. This solid dosage unit comprises: • 4-95% by weight of granules consisting of: - 3-80% by weight of an estetrol component selected from estetrol, estetrol esters and combinations thereof; - 20-97% by weight of C4-C12 sugar alcohol; - 0-45% by weight of one or more other pharmaceutically acceptable ingredients; and • 5-96% by weight of one or more pharmaceutically acceptable excipients. The solid dosage units of the present invention are particularly suitable for sublingual, buccal, or sublabial administration of the estetrol component. |
| priorityDate |
2013-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |